ZYXI Zynex Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ZYXI

Price (delayed)

$11.38

Market cap

$366.1M

P/E Ratio

42.15

Dividend/share

N/A

EPS

$0.27

Enterprise value

$397.28M

Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation; and the company's proprietary NeuroMove device designed to help recovery ...

Highlights
Zynex's revenue has increased by 17% YoY
The gross profit has grown by 16% YoY
ZYXI's quick ratio is up by 46% YoY but it is down by 11% QoQ
The debt has soared by 183% YoY
The P/E is 57% above the last 4 quarters average of 26.8 and 4.9% above the 5-year quarterly average of 40.2
Sector: Healthcare
Industry: Medical Devices
Website: http://www.zynex.com
Peers: RMTI MDT FONR

Key stats

What are the main financial stats of ZYXI
Market
Shares outstanding
32.17M
Market cap
$366.1M
Enterprise value
$397.28M
Valuations
Price to earnings (P/E)
42.15
Price to book (P/B)
8.36
Price to sales (P/S)
2.2
EV/EBIT
29.06
EV/EBITDA
21.14
EV/Sales
2.16
Earnings
Revenue
$184.32M
EBIT
$13.67M
EBITDA
$18.8M
Free cash flow
$16.6M
Per share
EPS
$0.27
Free cash flow per share
$0.47
Book value per share
$1.36
Revenue per share
$5.18
TBVPS
$3.05
Balance sheet
Total assets
$136.9M
Total liabilities
$90.78M
Debt
$76.17M
Equity
$46.13M
Working capital
$69.32M
Liquidity
Debt to equity
1.65
Current ratio
4.74
Quick ratio
3.88
Net debt/EBITDA
1.66
Margins
EBITDA margin
10.2%
Gross margin
79.2%
Net margin
5.3%
Operating margin
5.8%
Efficiency
Return on assets
7.1%
Return on equity
16.8%
Return on invested capital
12.3%
Return on capital employed
11.6%
Return on sales
7.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ZYXI stock price

How has the Zynex stock price performed over time
Intraday
-0.61%
1 week
-4.45%
1 month
-11.99%
1 year
-5.01%
YTD
4.5%
QTD
-8%

Financial performance

How have Zynex's revenue and profit performed over time
Revenue
$184.32M
Gross profit
$145.96M
Operating income
$10.78M
Net income
$9.73M
Gross margin
79.2%
Net margin
5.3%
Zynex's operating margin has shrunk by 60% YoY and by 42% QoQ
The company's operating income has shrunk by 53% YoY and by 42% QoQ
The net margin has plunged by 51% YoY and by 38% from the previous quarter
Zynex's net income has decreased by 43% YoY and by 39% from the previous quarter

Growth

What is Zynex's growth rate over time

Valuation

What is Zynex stock price valuation
P/E
42.15
P/B
8.36
P/S
2.2
EV/EBIT
29.06
EV/EBITDA
21.14
EV/Sales
2.16
The P/E is 57% above the last 4 quarters average of 26.8 and 4.9% above the 5-year quarterly average of 40.2
The EPS has contracted by 39% YoY and by 36% from the previous quarter
The P/B is 33% more than the last 4 quarters average of 6.3 but 18% less than the 5-year quarterly average of 10.2
The equity has declined by 30% year-on-year and by 21% since the previous quarter
The price to sales (P/S) is 54% lower than the 5-year quarterly average of 4.8 but 4.8% higher than the last 4 quarters average of 2.1
Zynex's revenue has increased by 17% YoY

Efficiency

How efficient is Zynex business performance
The ROIC has plunged by 61% YoY and by 42% from the previous quarter
ZYXI's ROA is down by 50% year-on-year and by 41% since the previous quarter
The ROS has contracted by 48% YoY and by 35% from the previous quarter
ZYXI's ROE is down by 34% since the previous quarter and by 32% year-on-year

Dividends

What is ZYXI's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Recent dividends

Financial health

How did Zynex financials performed over time
The total assets is 51% more than the total liabilities
Zynex's total liabilities has surged by 81% YoY but it has decreased by 2.2% QoQ
ZYXI's quick ratio is up by 46% YoY but it is down by 11% QoQ
The debt is 65% more than the equity
The debt has soared by 183% YoY
The equity has declined by 30% year-on-year and by 21% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.